Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|July 9, 2010
[Objectivity in research in the pharmaceutical industry is possible]Koen Torfs, Ina Rudolph, Angelika Mehnert, et al.
BMC Health Services Research|August 15, 2009
Preferences for treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): a discrete choice experimentAxel C Mühlbacher, Ina Rudolph, Hans-Joachim Lincke, et al.
The Patient|October 15, 2011
Can patients diagnosed with schizophrenia complete choice-based conjoint analysis tasks?John F P Bridges, Elizabeth T Kinter, Annette Schmeding, et al.
International Journal of Technology Assessment in Health Care|January 8, 2009
Identifying patient-relevant endpoints among individuals with schizophrenia: an application of patient-centered health technology assessmentElizabeth T Kinter, Annette Schmeding, Ina Rudolph, et al.
Transplantation and Cellular Therapy|November 15, 2025
Belumosudil for Chronic Graft-Versus-Host Disease: A Systematic Review and Meta-AnalysisKristin Rathje, Nico Gagelmann, Silke Heidenreich, et al.
Transplantation and Cellular Therapy|September 25, 2025
Remission Status Prior to Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia/Myelodysplastic Syndrome Patients Harboring Single-Hit or Multi-Hit p53 Mutations Does Not Impact OutcomeNormann Steiner, Evgeny Klyuchnikov, Anita Badbaran, et al.
Haematologica|July 16, 2026
Incidence, molecular and clinical characteristics of donor-derived hematologic malignancies after allogeneic stem cell transplantation for myeloid malignanciesTetiana Perekhrestenko, Anita Badbaran, Evgeny Klyuchnikov, et al.
British Journal of Haematology|June 18, 2025
Different clearance of KITD816V mutation and tryptase levels after haematopoietic cell transplantation in patients with systemic mastocytosis with associated haematological neoplasmChristian Niederwieser, Anita Badbaran, Radwan Massoud, et al.
European Journal of Haematology|September 20, 2024
Comparable Results Between 8 and 12 Gray TBI in Combination With Fludarabine and Post-Transplant Cyclophosphamide in MRD-Negative but Not in MRD-Positive Acute Lymphoblastic Leukemia Patients Transplanted in First Complete RemissionNormann Steiner, Radwan Massoud, Johanna Richter, et al.
Bone Marrow Transplantation|April 16, 2026
Outcomes of allogeneic transplantation in blast-phase myeloproliferative neoplasms: one-third achieve long-term survivalKordelia Barbullushi, Nico Gagelmann, Kristin Rathje, et al.
Pageof 2